PPSG
Princeton Portfolio Strategies Group’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $916K | Buy |
22,993
+1,350
| +6% | +$53.8K | 0.18% | 97 |
|
2021
Q1 | $772K | Buy |
21,643
+1,000
| +5% | +$35.7K | 0.15% | 107 |
|
2020
Q4 | $760K | Buy |
20,643
+6,000
| +41% | +$221K | 0.15% | 107 |
|
2020
Q3 | $551K | Sell |
14,643
-800
| -5% | -$30.1K | 0.12% | 110 |
|
2020
Q2 | $630K | Hold |
15,443
| – | – | 0.15% | 104 |
|
2020
Q1 | $585K | Hold |
15,443
| – | – | 0.17% | 96 |
|
2019
Q4 | $726K | Hold |
15,443
| – | – | 0.17% | 101 |
|
2019
Q3 | $659K | Hold |
15,443
| – | – | 0.16% | 99 |
|
2019
Q2 | $618K | Sell |
15,443
-40
| -0.3% | -$1.6K | 0.16% | 106 |
|
2019
Q1 | $647K | Sell |
15,483
-500
| -3% | -$20.9K | 0.17% | 107 |
|
2018
Q4 | $611K | Buy |
15,983
+500
| +3% | +$19.1K | 0.19% | 104 |
|
2018
Q3 | $622K | Sell |
15,483
-2,381
| -13% | -$95.7K | 0.16% | 110 |
|
2018
Q2 | $720K | Sell |
17,864
-10,662
| -37% | -$430K | 0.21% | 101 |
|
2018
Q1 | $1.12M | Sell |
28,526
-482
| -2% | -$18.8K | 0.32% | 84 |
|
2017
Q4 | $1.03M | Sell |
29,008
-2,394
| -8% | -$84.9K | 0.28% | 90 |
|
2017
Q3 | $1.28M | Buy |
31,402
+606
| +2% | +$24.6K | 0.35% | 75 |
|
2017
Q2 | $1.33M | Buy |
30,796
+1,607
| +6% | +$69.3K | 0.38% | 73 |
|
2017
Q1 | $1.23M | Buy |
29,189
+2,006
| +7% | +$84.6K | 0.37% | 74 |
|
2016
Q4 | $1.05M | Buy |
27,183
+7,700
| +40% | +$297K | 0.33% | 77 |
|
2016
Q3 | $840K | Sell |
19,483
-845
| -4% | -$36.4K | 0.26% | 84 |
|
2016
Q2 | $881K | Buy |
20,328
+3,075
| +18% | +$133K | 0.28% | 86 |
|
2016
Q1 | $700K | Buy |
17,253
+250
| +1% | +$10.1K | 0.24% | 92 |
|
2015
Q4 | $686K | Buy |
17,003
+600
| +4% | +$24.2K | 0.24% | 89 |
|
2015
Q3 | $631K | Buy |
16,403
+11,328
| +223% | +$436K | 0.26% | 80 |
|
2015
Q2 | $211K | Buy |
+5,075
| New | +$211K | 0.07% | 132 |
|